These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17045761

  • 1. The potential of retroviral vectors to cotransfer human endogenous retroviruses (HERVs) from human packaging cell lines.
    Zeilfelder U, Frank O, Sparacio S, Schön U, Bosch V, Seifarth W, Leib-Mösch C.
    Gene; 2007 Apr 01; 390(1-2):175-9. PubMed ID: 17045761
    [Abstract] [Full Text] [Related]

  • 2. MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency.
    Patience C, Takeuch Y, Cosset FL, Weiss RA.
    Dev Biol (Basel); 2001 Apr 01; 106():169-79; discussion 253-63. PubMed ID: 11761229
    [Abstract] [Full Text] [Related]

  • 3. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.
    Patience C, Takeuchi Y, Cosset FL, Weiss RA.
    J Virol; 1998 Apr 01; 72(4):2671-6. PubMed ID: 9525584
    [Abstract] [Full Text] [Related]

  • 4. Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats.
    Schön U, Seifarth W, Baust C, Hohenadl C, Erfle V, Leib-Mösch C.
    Virology; 2001 Jan 05; 279(1):280-91. PubMed ID: 11145909
    [Abstract] [Full Text] [Related]

  • 5. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
    Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M.
    J Gene Med; 1999 Jan 05; 1(3):195-209. PubMed ID: 10738568
    [Abstract] [Full Text] [Related]

  • 6. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
    Sandrin V, Muriaux D, Darlix JL, Cosset FL.
    J Virol; 2004 Jul 05; 78(13):7153-64. PubMed ID: 15194792
    [Abstract] [Full Text] [Related]

  • 7. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.
    Thaler S, Schnierle BS.
    Mol Ther; 2001 Sep 05; 4(3):273-9. PubMed ID: 11545619
    [Abstract] [Full Text] [Related]

  • 8. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
    Engelstädter M, Buchholz CJ, Bobkova M, Steidl S, Merget-Millitzer H, Willemsen RA, Stitz J, Cichutek K.
    Gene Ther; 2001 Aug 05; 8(15):1202-6. PubMed ID: 11509952
    [Abstract] [Full Text] [Related]

  • 9. Transcription start regions in the human genome are favored targets for MLV integration.
    Wu X, Li Y, Crise B, Burgess SM.
    Science; 2003 Jun 13; 300(5626):1749-51. PubMed ID: 12805549
    [Abstract] [Full Text] [Related]

  • 10. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH, Miletic H, Giroglou T, Litwak S, Stenzel W, Neumann H, von Laer D.
    J Gene Med; 2007 May 13; 9(5):335-44. PubMed ID: 17474071
    [Abstract] [Full Text] [Related]

  • 11. Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors.
    Pizzato M, Merten OW, Blair ED, Takeuchi Y.
    Gene Ther; 2001 May 13; 8(10):737-45. PubMed ID: 11420637
    [Abstract] [Full Text] [Related]

  • 12. High efficiency retroviral vectors that contain no viral coding sequences.
    Yu SS, Kim JM, Kim S.
    Gene Ther; 2000 May 13; 7(9):797-804. PubMed ID: 10822307
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of retroviral production from packaging cell lines expressing the human immunodeficiency type 1 VPU gene.
    Kobinger GP, Mouland AJ, Lalonde JP, Forget J, Cohen EA.
    Gene Ther; 1997 Aug 13; 4(8):868-74. PubMed ID: 9338017
    [Abstract] [Full Text] [Related]

  • 14. Generation of a flexible cell line with regulatable, high-level expression of HIV Gag/Pol particles capable of packaging HIV-derived vectors.
    Sparacio S, Pfeiffer T, Schaal H, Bosch V.
    Mol Ther; 2001 Apr 13; 3(4):602-12. PubMed ID: 11319923
    [Abstract] [Full Text] [Related]

  • 15. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus.
    Ponferrada VG, Mauck BS, Wooley DP.
    Arch Virol; 2003 Apr 13; 148(4):659-75. PubMed ID: 12664292
    [Abstract] [Full Text] [Related]

  • 16. Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.
    Blesch A.
    Methods; 2004 Jun 13; 33(2):164-72. PubMed ID: 15121171
    [Abstract] [Full Text] [Related]

  • 17. Specific packaging of spliced retroviral vector transcripts lacking the Psi-region.
    Pambalk K, Hohenadl C, Salmons B, Günzburg WH, Renner M.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):239-46. PubMed ID: 12054590
    [Abstract] [Full Text] [Related]

  • 18. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S, Biese P, Cosset FL, Takeuchi Y, Uckert W.
    Gene Ther; 2007 Apr 26; 14(7):595-603. PubMed ID: 17235289
    [Abstract] [Full Text] [Related]

  • 19. A murine leukemia virus derived retroviral vector with a rat VL30 packaging psi sequence.
    Torrent C, Wang P, Darlix JL.
    Bone Marrow Transplant; 1992 Apr 26; 9 Suppl 1():143-7. PubMed ID: 1324044
    [Abstract] [Full Text] [Related]

  • 20. Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies.
    Mant C, Gillett C, D'Arrigo C, Cason J.
    Virology; 2004 Jan 05; 318(1):393-404. PubMed ID: 14972564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.